Bharat Seats shares jumped 5.48% to Rs 212 on Thursday, touching an intraday high of Rs 221.94, after the Maruti Suzuki supplier reported strong full-year revenue growth, a 16% rise in quarterly profit and approved Rs 86.61 crore in capital expenditure for new Maruti programmes — a forward order book signal that the market has reacted to positively.
The capex approval is the key catalyst beyond the results. The board approved investment across Bharat Seats’ plants at Kharkhoda — where Maruti’s new greenfield facility is being built — and Gujarat Navyani, directly linking the company’s growth to Maruti’s own capacity expansion. For a supplier of seating systems, winning new programmes at the Kharkhoda plant positions Bharat Seats to participate in Maruti’s next phase of volume growth as the facility ramps up.
The Q4 and full year numbers
Q4 FY26 revenue surged 46.2% year-on-year to Rs 574.27 crore from Rs 392.91 crore, with net profit rising 16.4% to Rs 13.25 crore. EBITDA grew to Rs 29.6 crore from Rs 22.7 crore, though EBITDA margin contracted to 5.17% from 5.78% — a common pattern for auto component suppliers facing rising input costs and fixed-price contracts.
For the full year FY26, revenue from operations grew 51.4% to Rs 1,950.95 crore from Rs 1,288.82 crore — one of the strongest topline expansions in the auto ancillary space this results season. Net profit for FY26 rose to Rs 42.23 crore from Rs 32.70 crore. Full-year EPS improved to Rs 6.72 from Rs 5.21.
The board recommended a final dividend of Rs 1.50 per share with a record date of July 17, 2026, and fixed the 39th AGM for July 24, 2026.
At Rs 212, the shares remain well below their 52-week high of Rs 239.45, leaving room for further recovery as the Kharkhoda ramp and new programme revenues flow through in FY27.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Please consult a qualified financial advisor before making investment decisions.